← Companies|Hua Medicine
25

Hua Medicine

2552.HK·HKEXShanghai CNFounded 2010200 employees
Micro CapbiotechPublicMetabolic
Platform: Dorzagliatin
Market Cap
$0.2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (2552.HK)
Loading 2552.HK stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
255-7731255-7731Phase 11PeptideEZH2MDM2iRBWilms
Polatapinarof255-5081Phase 11siRNAPRMT5BCL-2iSchizophrenia
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Hua Medicine trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)
2025-12-27
255-7731 Orphan Drug
Wilms
Past
2029-11-04
Polatapinarof Interim
Schizophrenia
Interim